Curriculum Vitae
of Breffni
Martin
Breffni
Martin was educated at Cistercian College
Roscrea and University College Dublin, where he
graduated in Biology in 1983. He spent the next
20 years in the pharmaceutical industry in a
variety of areas including the following:
-
US and
international regulatory
affairs
-
Licensing
-
FDA
compliance and
inspection
-
Technology
transfer
-
Analytical
science
-
Auditing
-
Validation
-
Writing
(scientific/regulatory/medical/French-English
translation)
-
Laboratory
Information Systems (to support QC, pharm/tox,
biological screening
etc)
Professional
Experience
Director
CanReg (Europe)
Ltd Since
January 2004
CanReg (Europe) is
the European subsidiary of CanReg
Inc , the largest regulatory services
company in Canada. CanReg specialises in
providing high-quality low-cost regulatory
services for North America including the
following:
-
Clinical trial
applications
-
New Drug
Applications/Submissions including the
CTD
-
Notifiable
changes and variations
-
Quality and
compliance services
-
Regulatory
services
-
Reimboursement
-
Training
Director
RegIntel
Ltd
2003 - Present
Ireland
Founded RegIntel
Limited, an Irish-based consultancy specialising
in regulatory intelligence and
licensing
Director
Product Development, Business
Development
IMS Health,
IH Inc and Liquent
Inc.
1997 -
2002
Paris,
France
IDRAC is
an on-line database of regulatory information
covering the whole drug development lifecycle in
over 30 countries. Breffni Martin managed
content for the US and developed content for
Japan, the UK, Ireland, Canada, Australia, Latin
America, South East Asia, Scandinavia, Greece.
Most
recently he created and launched the AdComm
Bulletin, which covers human drug advisory
committee meetings run by FDA and has been well
received by
industry.
Freelance
Consultant
Paris,
France, and USA
1995 -
1997
Clients
included:
-
IBM Medical
(telemedicine)
-
Notocord SA
(pharm/tox
software)
-
Biologie
& Industrie (medical
writing)
- Servier
(medical writing)
- Pfizer
(auditing)
Regulatory, Compliance
Manager; Analytical
Services Director
GSK
Singapore
1992 -
1995
Part of a
multi-disciplinary team responsible for
commissioning a $300 million multi-purpose
manufacturing facility for supplying the US
market, with specific responsibility for
regulatory affairs, all analytical matters on
site, validation (systems, software, analytical
methodology), hiring and training a staff of
more than 40 scientists.
API's for
Imigran, Zofran, and Severent successfully
commissioned for US and Japanese
markets.
Medical
and Promotional
Writer
Hong Kong
and SE Asia
1991
Clients
included:
-
Medica
Excerpta, HK Trade Development Council, Asian
Sources (medical and promotional
writing)
-
Concordia -
paper recycling (completed an environmental
impact assessment
report)
Pharmaceutical
Development
Manager